MeSH D014860 - warts
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Podofilox | Condylox | 1997-03-13 | |||
| Bausch Health Companies | Podofilox | Podofilox | 2010-07-21 | |||
| Horizon Therapeutics Public | Interferon gamma-1b | Actimmune | 1999-02-25 | $122.816 M | Q3/22-Q2/23 | |
| Padagis | Podofilox | Podofilox | 2002-01-29 | |||
| Teva | Podofilox | Condylox | 1990-12-13 | |||
| Verrica Pharmaceuticals | Cantharidin | Ycanth | 2035-05-28 | 2023-07-21 |
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
17%2/12
Phase 3
70%7/10
Approved: 7Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use